SCHEMBL23859909

SCHEMBL23859909

C[SiH]C.Cc1ccc2c(c1)C([Hf](Cl)(Cl)C1c3ccccc3-c3ccc(C)cc31)c1ccccc1-2

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.37
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 2/20 0.33
CYP1A2 P05177 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
GPR3 P46089 1/20 0.32
PPIA P62937 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21519875 0.85 ELANE (0.38) ELANEHSD17B1HSD17B2KMT2AALDH1A1
SCHEMBL14492674 0.70 HTR7 (0.46) ELANEHSD17B1HSD17B2KMT2AALDH1A1
SCHEMBL30431051 0.70 HTR7 (0.46) ELANEHSD17B1HSD17B2KMT2AALDH1A1
SCHEMBL16230462 0.68 HTR7 (0.47) ELANEHSD17B1HSD17B2KMT2AALDH1A1
SCHEMBL8749961 0.68 PGR (0.48) ELANEHSD17B1HSD17B2KMT2AALDH1A1
Hydrochloric Acid SCHEMBL4632310 0.68 ELANE (0.44) ELANEHSD17B1HSD17B2KMT2AALDH1A1
Hydrochloric Acid SCHEMBL5355296 0.67 ELANE (0.42) ELANEHSD17B1HSD17B2KMT2AALDH1A1
SCHEMBL15362284 0.66 ELANE (0.41) ELANEHSD17B1HSD17B2KMT2AALDH1A1
SCHEMBL22068817 0.66 GAA (0.49) ELANEKMT2AALDH1A1KDM4ENPC1
SCHEMBL28482076 0.66 ELANE (0.41) ELANEHSD17B1HSD17B2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12528892-B2 Alkylation of transition metal coordination catalyst complexes EXXONMOBIL CHEMICAL PATENTS INC. (US) 2026-01-20 US disclosed
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes EXXONMOBIL CHEMICAL PATENTS INC (US) 2023-05-11 US disclosed
WO-2021194831-A1 ALKYLATION OF TRANSITION METAL COORDINATION CATALYST COMPLEXES EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528892-B2 Alkylation of transition metal coordination catalyst complexes LEF1, TAF1, FLI1 ELANE 776/4885HSD17B1 3444/4885HSD17B2 3561/4885
US-20230141606-A1 Alkylation of Transition Metal Coordination Catalyst Complexes AS3MT, AP1M1, AP3M1 ELANE 2272/4885HSD17B1 4345/4885HSD17B2 4373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.